Oncorus Balance Sheet Health
Financial Health criteria checks 2/6
Oncorus has a total shareholder equity of $31.1M and total debt of $20.5M, which brings its debt-to-equity ratio to 66%. Its total assets and total liabilities are $109.8M and $78.6M respectively.
Key information
66.0%
Debt to equity ratio
US$20.54m
Debt
| Interest coverage ratio | n/a |
| Cash | US$44.98m |
| Equity | US$31.12m |
| Total liabilities | US$78.63m |
| Total assets | US$109.75m |
Recent financial health updates
Recent updates
Oncorus GAAP EPS of -$0.74 misses by $0.02
Aug 04We're Not Very Worried About Oncorus' (NASDAQ:ONCR) Cash Burn Rate
Oct 14
Oncorus: Shares Look Cheap As First Oncolytic Viral Therapy Enters Clinic
Jul 09Oncorus (NASDAQ:ONCR) Is In A Good Position To Deliver On Growth Plans
May 05What Kind Of Shareholders Own Oncorus, Inc. (NASDAQ:ONCR)?
Feb 26Oncorus: Buy On A Dip, Potential Already Priced In At Current Levels
Feb 02Oncorus to build viral immunotherapy clinical manufacturing facility in U.S.
Jan 04We're Not Very Worried About Oncorus' (NASDAQ:ONCR) Cash Burn Rate
Jan 04Oncorus reports Q3 results
Nov 11Financial Position Analysis
Short Term Liabilities: ONCR's short term assets ($46.7M) exceed its short term liabilities ($31.1M).
Long Term Liabilities: ONCR's short term assets ($46.7M) do not cover its long term liabilities ($47.5M).
Debt to Equity History and Analysis
Debt Level: ONCR has more cash than its total debt.
Reducing Debt: ONCR's debt to equity ratio has increased from 0% to 66% over the past 5 years.
Balance Sheet
Cash Runway Analysis
For companies that have on average been loss-making in the past, we assess whether they have at least 1 year of cash runway.
Stable Cash Runway: Insufficient data to determine if ONCR has enough cash runway based on its current free cash flow.
Forecast Cash Runway: Insufficient data to determine if ONCR has enough cash runway if its free cash flow continues to grow or shrink based on historical rates.